Depomed, Xanodyne Pharmaceuticals sales and marketing update

Depomed acquired pain drug Zipsor diclofenac from Xanodyne for $25.9 million in cash. Xanodyne is also eligible for a $2 million milestone at the end of the first year in which Zipsor net sales excee...